Evidence map›Paper›PMID 35690598›Full record

ArticleScientific reports2022

Effects of short chain fructo-oligosaccharides on selected skin bacteria.

Cindy Le Bourgot, Claire Meunier, Elisa Gaio, Vincent Murat, Marta Micheletto, Erik Tedesco, Federico Benetti

Open access · goldAbstract read
In one paragraph

Article in Scientific reports, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
1.9field-weighted citation impact, top 15% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 13 citations in OpenAlex.

  1. Review
  2. Review
  3. Article
  4. Review
  5. Review
  6. Review
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 1 institution in 1 country.

Cindy Le BourgotTereos, R&D Department, Rue de Senlis, 77290, Moussy-Le-Vieux, France. cindy.lebourgot@tereos.com.
Claire MeunierTereos, R&D Department, Rue de Senlis, 77290, Moussy-Le-Vieux, France.
Elisa GaioECSIN-ECAMRICERT SRL Laboratory, Corso Stati Uniti, 4, 35127, Padua, Italy.
Vincent MuratTereos, R&D Department, Rue de Senlis, 77290, Moussy-Le-Vieux, France.
Marta MichelettoECSIN-ECAMRICERT SRL Laboratory, Corso Stati Uniti, 4, 35127, Padua, Italy.
Erik TedescoECSIN-ECAMRICERT SRL Laboratory, Corso Stati Uniti, 4, 35127, Padua, Italy.
Federico BenettiECSIN-ECAMRICERT SRL Laboratory, Corso Stati Uniti, 4, 35127, Padua, Italy.
Valeo (France) · FR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The human skin microbiota plays a key role in the maintenance of healthy skin, ensuring protection and biological barrier by competing with pathogens and by closely communicating with the immune system. The development of approaches which preserve or restore the skin microbiota represents a novel target for skincare applications. Prebiotics could be applied to balance almost any microbial community to achieve advantageous effects. However, information about their effectiveness as skin microbiota modulators is limited. The objective of the current study was to evaluate the effects of short chain fructo-oligosaccharides (scFOS) from sugar beet (DP 3-5), well-recognised prebiotics, on some representative bacterial strains of the skin microbiota. We measured the growth and competitive activity of these specific bacteria for the use of scFOS as energy source in minimal medium and in a reconstructed human epithelium (RHE) in vitro model. In minimal growth medium, scFOS promoted and sustained the growth of Staphylococcus epidermidis up to 24 h, considered a beneficial skin commensal bacterium, while inhibiting both Cutibacterium acnes and Staphylococcus aureus growth, regarded as opportunistic pathogens. S. epidermidis showed the highest colonization potential and 1% scFOS was effective in shifting the competition in favour of S. epidermidis with respect to C. acnes in the RHE model. This latter effect was observed following 24 h of exposure, suggesting a long-term effect of scFOS in a highly skin dynamic environment. Therefore, scFOS could be effectively implemented in skincare formulations for recovering skin microbiota homeostasis.

Indexed as

MicrobiotaPrebioticsHumansOligosaccharidesPropionibacterium acnesSkinStaphylococcus epidermidisOligosaccharidesPrebiotics

Identifiers

PMID35690598
PMCPMC9188601
OpenAlexW4282923261

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.